in Philadelphia-Chromosome-Negative Acute Lymphoblastic Leukemia, Late Relapses Are Not Uncommon, Occur Mostly in Patients at Standard Risk and Have a Relatively Favorable Outcome. Results of the International ALL Trial: MRC Ukallxii/ECOG E2993
Authors
Ganzel, CVictoria, W
Fielding, A
Rowe, J
Richards, S
Buck, G
Chopra, Rajesh
Durrant, I
Marks, D
Franklin, I
McMilan, A
Litzow, M
Paietta, E
Luger, S
Wiernik, P
Douer, D
Lazarus, H
Tallman, M
Goldstone, A
Affiliation
Hematology, Shaare Zedek Medical Center, Jerusalem, IsraelIssue Date
2015